Corbevax information

Corbevax
Vaccine description
Target	SARS-CoV-2
Vaccine type	Protein subunit
Clinical data
Trade names	Corbevax
Other names	BECOV2D, Biological E COVID-19
Routes of; administration	Intramuscular
ATC code	J07BN04 (WHO) ;
Legal status
Legal status	Full list of Corbevax authorizations;

Corbevax is a protein subunit COVID-19 vaccine^[1]^[2]^[3]^[4] developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California.^[5]^[6] It is licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.^[7]^[8]

^ "A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers". ctri.nic.in. Clinical Trials Registry India. 13 January 2021. CTRI/2020/11/029032. Archived from the original on 12 November 2020.
^ "CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate". cepi.net. CEPI. 29 December 2020. Archived from the original on 29 December 2020. Retrieved 5 March 2021.
^ Chui M (16 November 2020). "Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India". Baylor College of Medicine.
^ Leo L (16 November 2020). "Biological E initiates human trials of vaccine". Mint.
^ Hotez PJ, Bottazzi ME (January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55–64. doi:10.1146/annurev-med-042420-113212. PMID 34637324. S2CID 238747462.
^ "Covovax and Corbevax: What we know about India's new Covid vaccines". BBC News. 28 December 2021.
^ Raghavan P (10 June 2021). "Explained: How is Biological E's Corbevax different?". The Indian Express. Retrieved 29 December 2021.
^ "Covovax and Corbevax: What we know about India's new Covid vaccines". BBC News. 28 December 2021.

[1] "A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers". ctri.nic.in. Clinical Trials Registry India. 13 January 2021. CTRI/2020/11/029032. Archived from the original on 12 November 2020.

[BioE1-2] "CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate". cepi.net. CEPI. 29 December 2020. Archived from the original on 29 December 2020. Retrieved 5 March 2021.

[BioE-3] Chui M (16 November 2020). "Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India". Baylor College of Medicine.

[Leo_2020-4] Leo L (16 November 2020). "Biological E initiates human trials of vaccine". Mint.

[Hotez-5] Hotez PJ, Bottazzi ME (January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55–64. doi:10.1146/annurev-med-042420-113212. PMID 34637324. S2CID 238747462.

[6] "Covovax and Corbevax: What we know about India's new Covid vaccines". BBC News. 28 December 2021.

[7] Raghavan P (10 June 2021). "Explained: How is Biological E's Corbevax different?". The Indian Express. Retrieved 29 December 2021.

[8] "Covovax and Corbevax: What we know about India's new Covid vaccines". BBC News. 28 December 2021.

Corbevax information

and 24 Related for: Corbevax information

Corbevax

Maria Elena Bottazzi

Lyme disease

CoWIN

Infection

Tetanus vaccine

WHO Model List of Essential Medicines

Louis Pasteur

Rabies vaccine

Vaccine

Cholera vaccine

HPV vaccine

Edward Jenner

BCG vaccine

Leptospirosis

DPT vaccine

MRNA vaccine

Inactivated vaccine

Peter Hotez

Epidemiology

Gardasil

Postherpetic neuralgia

Uromune

Polio vaccine

COVID-19 pandemic
Part of a series on the
Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom.
COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths
Timeline 2019 2020 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2021 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November responses December responses 2022 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November December 2023
Locations By country and territory Africa Antarctica Asia Europe North America Oceania South America By conveyance Cruise ships Naval ships
International response Endemic phase Evacuations Face masks International aid Origin Lockdowns by country Misinformation by governments Fake treatments Social distancing Software Travel United Nations World Health Organization WTO IP waiver Undercounting of deaths COVID-19 apps Zero-COVID National responses Africa China European Union Germany Ghana India Ireland Netherlands New Zealand Nigeria Philippines Russia Sweden UK government US federal government Vietnam
Medical response Disease testing Breathalyzer Development Drug development Drug repurposing Public health mitigation Vaccines History Research VITT Deployment Authorizations Operation Warp Speed Misinformation and hesitancy US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sinopharm BIBP Sputnik V
Variants Variants of concern Alpha Beta Gamma Delta Omicron Other variants Epsilon Zeta Eta Theta Iota Kappa Lambda Mu Cluster 5 Lineage B.1.617
Economic impact and recession Arts and culture Aviation Cannabis Cinema films Disney Fashion Financial markets Food industry Food security Journalism Music Performing arts Retail Shipping Television US sportscasting programs Tourism Video games By country Canada India Ireland Malaysia New Zealand Russia UK US By sport Association football Baseball Basketball Combat sports Cricket Disc golf Gaelic games Gridiron football Ice hockey Motorsport Rugby league
Impacts Animals Alzheimer's disease patients Black people Crime Death rates by country Disability Domestic violence Emergency evacuations Education Female Environment Hospitals Language LGBT community Long-term care Media coverage Mental health symptoms Migration Military Notable deaths Other health issues Politics diplomacy Popular culture Protests Pregnancy Prisons Religion Catholic Church Hajj Science and technology Social media Strikes Suicides Telehealth Xenophobia and racism Society Ireland Malaysia New Zealand Russia UK US
COVID-19 portal
v t e